Urgent need for disease-modifying drugs to arrest Parkinson’s disease progression: GlobalData Read more
300 per cent increase in companies conducting endometriosis clinical trials since 2010: GlobalData Read more
Chemotherapy uptake to gradually decrease with arrival of novel therapies and biosimilars- GlobalData Read more
Cipla takes deal route with Alvotech to enter Australian autoimmune biosimilars market: GlobalData Read more
Mylan-UpJohn merger as Viatris provides opportunity to focus on biosimilar launch and uptake Read more